SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-13-004958
Filing Date
2013-01-28
Accepted
2013-01-28 08:03:12
Documents
3
Period of Report
2013-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 1ST PATIENT TREATED PRESS RELEASE rrd367881.htm 8-K 12704
2 LOGO ljpclogo.jpg GRAPHIC 21134
3 PRESS RELEASE DATED JANUARY 28, 2013 rrd367881_39137.htm EX-99 6232
  Complete submission text file 0001181431-13-004958.txt   49327
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 13550141
SIC: 2836 Biological Products, (No Diagnostic Substances)